 CAMBRIDGE, Mass., March 21, 2022 GLOBE NEWSWIRE -- Cerevel Therapeutics Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that chairperson and chief executive officer, Tony Coles, M.D. will participate in a fireside chat at the Stifel 4th Annual CNS Day on Tuesday, March 29, 2022 at 9:00 a.m. EDT. 